Back to Search
Start Over
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.
- Source :
- Alimentary Pharmacology and Therapeutics, Vol. 37, no.8, p. 767-775 (2013)
- Publication Year :
- 2013
-
Abstract
- When combined with mesalazine enema, prolonged-release mesalazine once-daily 4 g is as effective and well tolerated as 2 g twice-daily for inducing remission in patients with mild-to-moderately active ulcerative colitis (Clinicaltrials.gov: NCT00737789).
Details
- Database :
- OAIster
- Journal :
- Alimentary Pharmacology and Therapeutics, Vol. 37, no.8, p. 767-775 (2013)
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1130496297
- Document Type :
- Electronic Resource